Aultman Hospital

Futó vizsgálatok

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Forrás

• Fut, nem toboroz

  An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  NCT07517263· 3. fázis· Forrás

• Toboroz

  Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT07222566· 3. fázis· Forrás

• Toboroz

  A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  NCT07174336· 3. fázis· Forrás

• Toboroz

  Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  NCT06909565· 4. fázis· Forrás

• Toboroz

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· 3. fázis· Forrás

• Toboroz

  The Fourth Left Atrial Appendage Occlusion Study

  NCT05963698· Forrás

• Fut, nem toboroz

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· 3. fázis· Forrás

• Fut, nem toboroz

  EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

  NCT05284747· 4. fázis· Forrás

• Fut, nem toboroz

  Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

  NCT05360446· 3. fázis· Forrás

• Toboroz

  GEMINI-NSCLC: NSCLC Biomarker Study

  NCT05236114· Forrás

• Toboroz

  Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

  NCT05234177· Forrás

• Fut, nem toboroz

  A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

  NCT04975308· 3. fázis· Forrás

• Fut, nem toboroz

  Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

  NCT03281954· 3. fázis· Forrás

• Toboroz

  Integrated Cancer Repository for Cancer Research

  NCT02012699· Forrás

• Fut, nem toboroz

  Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

  NCT01844986· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák4 toboroz
• Vastagbélrák2 toboroz
• Áttétes emlőrák1 toboroz
• Elhízás1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Mezotelióma1 toboroz
• Mielóma multiplex1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz
• Petefészekrák1 toboroz
• Pitvarfibrilláció1 toboroz
• Prosztatarák1 toboroz
• Stroke (szélütés)1 toboroz
• Szarkóma1 toboroz
• Szívelégtelenség1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer

  NCT04892472· 2. fázis· Forrás

• Lezárult

  Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

  NCT04873934· 3. fázis· Forrás

• Lezárult

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· 3. fázis· Forrás

• Lezárult

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· 3. fázis· Forrás

• Lezárult

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Forrás

• Leállították

  Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

  NCT02928497· Forrás

• Lezárult

  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

  NCT01996865· 3. fázis· Forrás